2 - Higher Sessile Serrated Lesion Detection Rates Are Associated With Lower Risk for Post-Colonoscopy Colorectal Cancer: Data From the New Hampshire Colonoscopy Registry
3 - Comparison of EMR, ESD, and EFTR for Endoscopic Resection of Duodenal and Rectal Neuroendocrine Tumors
Location: North Ballroom 120D
Presenting Author: Joy Zhao, MD – Thomas Jefferson University
Oral Paper PresentationAnnual Scientific Meeting
Monday, Oct 27th
8:36 AM - 8:48 AM PDT
4 - Efficacy and Safety of Subcutaneous Guselkumab Induction and Maintenance Therapy in Participants With Ulcerative Colitis: Results Through Week 48 From the Phase 3 ASTRO Study
7 - Treatment With Resmetirom for up to Two Years Led to Improvement in Liver Stiffness, Fibrosis Biomarkers, Fibrosis Scores, and Portal Hypertension Risk in 122 Patients With Compensated MASH Cirrhosis
8 - Associations Between Early Fluid Resuscitation, SIRS Status, and BUN Changes in Acute Pancreatitis: Real World Results From the APPRENTICE Consortium
Paper Session Moderator: Shifa Umar, MD – Baylor College of Medicine
Oral Paper PresentationAnnual Scientific Meeting
Monday, Oct 27th
2:15 PM - 2:25 PM PDT
11 - Significant and Durable Microbiome Restoration in a Phase 3 Trial of Fecal Microbiota, Live-JSLM for Recurrent Clostridioides difficile Infection When Administered by Colonoscopy
16 - Characterizing Treatment Satisfaction and Health-Related Quality of Life of Patients With Exocrine Pancreatic Insufficiency (EPI) Taking Pancreatic Enzyme Replacement Therapy (PERT): Findings From the PACT-CP Registry
17 - Evaluating the Cost of Surveillance in Pancreatic Cysts of Low-Risk Features in Patients Over 70-Years-Old
Location: North Ballroom 120BC
Presenting Author: Shaina Ailawadi, MD – Case Western Reserve University/University Hospitals
Oral Paper PresentationAnnual Scientific Meeting
Monday, Oct 27th
2:45 PM - 2:55 PM PDT
14 - Risks of Gastrointestinal Malignancies in Short Bowel Syndrome Patients Treated With Teduglutide: Results From TriNetX
Location: North Ballroom 120D
Presenting Author: Nurlan Aliyev, MD – University of Nebraska Medical Center
Oral Paper PresentationAnnual Scientific Meeting
Monday, Oct 27th
2:45 PM - 2:55 PM PDT
18 - High Performance of a Blood-Based Biomarker Test to Detect Early-Stage Pancreatic Cancer in a High-Risk Population, Across Two Independent Clinical Validation Studies
20 - Predictors of Rehospitalization in Patients With Immune Checkpoint Inhibitor Colitis
Location: North Ballroom 120D
Presenting Author: Shilpa Grover, MD, MPH – Brigham and Women's Hospital, Harvard Medical School
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 28th
8:40 AM - 8:50 AM PDT
29 - Change in Pruritus in Patients With Primary Biliary Cholangitis and Moderate to Severe Pruritus: A Pooled Analysis From the RESPONSE and ENHANCE Studies
Location: North Ballroom 120BC
Presenting Author: Marlyn J. Mayo, MD, FACG – Division of Digestive and Liver Diseases, University of Texas Southwestern
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 28th
8:50 AM - 9:00 AM PDT
21 - Factors Associated With Referral for Genetic Counseling in Patients With 10-99 Cumulative Colorectal Adenomas: A Single Center Retrospective Study
30 - Outcomes of Liver and Cardiovascular Metabolic Diseases Among Lean vs Non-Lean Individuals With Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis
31 - Comparative Efficacy of Tirzepatide vs. Semaglutide on Liver and Cardiovascular Related Outcomes in Patients with MASLD/MASH, Obesity, and Type 2 Diabetes Mellitus: A Real-World Cohort Study
23 - Virtual Multidisciplinary GI Clinic Improves Patient Engagement, Satisfaction, and Symptoms at Reduced Costs and Healthcare Utilization: A Propensity-Matched Prospective Observational Study
32 - Phenotyping MASLD Using Unsupervised Clustering of Liver and Metabolic Traits in NHANES (2017–2018)
Location: North Ballroom 120BC
Presenting Author: Varun Jain, MD – University of Pittsburgh Medical Center
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 28th
9:20 AM - 9:30 AM PDT
24 - Does Mild Endoscopic Disease Drive Persistent Symptoms in Crohn’s Disease? A Repeated Measures Analysis
Location: North Ballroom 120D
Presenting Author: Carl Samaha, MD – University of Pittsburgh
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 28th
9:20 AM - 9:30 AM PDT
33 - "Early Is Not Always Better": Impact of Endoscopy Timing in Cirrhotic Patients with Acute Variceal Bleeding - An Updated Systematic Review and Meta-Analysis
34 - Clinical Outcomes Following Percutaneous Gastrostomy Tube Placement in Patients With Compensated and Decompensated Cirrhosis: A Retrospective Matched Cohort Study
Location: North Ballroom 120BC
Presenting Author: Mohamed Eldesouki, MD – Saint Michael's Medical Center, New York Medical College
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 28th
9:40 AM - 9:50 AM PDT
26 - Both Low (TECH) and High (TEAM) Touch Interventions Improve Behavioral Health, IBD Symptoms, and Quality of Life: A Randomized Control Trial
35 - Early versus Delayed Cholecystectomy in Patients Admitted for Choledocholithiasis: Impact on Biliary Complications and Role of Sphincterotomy or Stenting
36 - The Use of Rectal Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Is Safe and Effective in Patients with Early-Stage CKD Undergoing ERCP: A Comparative Matched Analysis of Real-World Data
46 - Real-World Study of Biopsy Practices During Food Impactions in the Emergency Department: Multi-State GI Practice
Location: North Ballroom 120BC
Presenting Author: Walker D. Redd, MD, MSCR – Center for Gastrointestinal Biology and Disease, University of North Carolina School of Medicine
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 28th
2:25 PM - 2:35 PM PDT
38 - Indwelling Pleural Catheter as a Safe and Convenient Alternative to Serial Thoracentesis for the Management of Hepatic Hydrothorax: A Retrospective Propensity-Matched Cohort Study
Location: North Ballroom 120D
Presenting Author: Azhar Hussain, MBBS – SUNY Upstate Medical University Hospital
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 28th
2:25 PM - 2:35 PM PDT
47 - Utilization of the Glasgow-Blatchford Score to Guide Safe Disposition of Patients Admitted With Upper GI Bleeding: A Quality Improvement Research Project
50 - Clinical Characteristics, Management, and Survival Outcomes Differ Across Morphological Subtypes of Gastric Antral Vascular Ectasia (GAVE): A Retrospective Comparative Study
43 - Neuroimaging in Veterans With Irritable Bowel Syndrome (IBS): Analysis of the TRACTS (Translational Research Center for Traumatic Brain Injury and Stress Disorders) Longitudinal Prospective Cohort Study
Location: North Ballroom 120D
Presenting Author: Marisa Wu, MD – Boston Medical Center
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 28th
3:15 PM - 3:25 PM PDT
52 - Clinical Characteristics of Patients With Colonic Oligopolyposis of Unknown Etiology: A Single-Center Experience
44 - Trends and Disparities in Mortality From Obesity-Associated Gastrointestinal Cancers in the United States, 1999–2020: A CDC WONDER Analysis
Location: North Ballroom 120D
Presenting Author: Usama Sakhawat, MD – United Health Services, Wilson Medical Center
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 28th
3:25 PM - 3:35 PM PDT
53 - Early Colon Adenoma Development Following Immune Checkpoint Inhibitor Colitis: Implications for Prompt Surveillance Colonoscopy
Location: North Ballroom 120BC
Presenting Author: Tanvi Gupta, MD – University of Texas Health Science Center
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 28th
3:35 PM - 3:45 PM PDT
45 - A Placebo-Controlled Trial of CGRP Antagonist Rimegepant on Visceral Sensation and Symptoms in Participants With Non-Constipated IBS Pain (Late-Breaking Abstract)
Location: North Ballroom 120D
Late Breaking Abstract Presenter: Ayah Matar, MD – Mayo Clinic
Oral Paper PresentationAnnual Scientific Meeting
Tuesday, Oct 28th
3:35 PM - 3:45 PM PDT
54 - Feasibility of Targeted Pancreatic Cooling in Acute Pancreatitis: A Prospective, First-in-Human, Multi-Center Study (Late-Breaking Abstract)
Location: North Ballroom 120BC
Late Breaking Abstract Presenter: Walter Park, MD, MS – Stanford University School of Medicine
65 - Efficacy and Safety of Icotrokinra, a Targeted Oral Peptide That Selectively Blocks IL-23 Receptor Activation, in Ulcerative Colitis: Results From Week 28 of ANTHEM-UC, a Phase 2b Dose-Ranging Trial
Location: North Ballroom 120BC
Presenting Author: Vipul Jairath, MBChB, DPhil, MRCP – Department of Medicine and Department of Epidemiology and Biostatistics, Western University
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 29th
8:40 AM - 8:50 AM PDT
56 - Therapeutic Potential of Gastro-Gastric Fistulas Created via Lumen-Apposing Metal Stents for Nutritional Deficiencies in Roux-en-Y Gastric Bypass Patients: A Multicenter Study
66 - Duvakitug, an anti-TL1a mAb, Demonstrates Efficacy and Favorable Safety as an Induction Treatment in Adults With Moderately to Severely Active Crohn’s Disease: Results From the RELIEVE UCCD Phase 2b Basket Trial
Location: North Ballroom 120BC
Presenting Author: Vipul Jairath, MBChB, DPhil, MRCP – Department of Medicine and Department of Epidemiology and Biostatistics, Western University
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 29th
8:50 AM - 9:00 AM PDT
57 - Close, Coat, or Leave Alone? Evaluating Options to Reduce Delayed Bleeding in Endoscopic Submucosal Dissection
Location: North Ballroom 120D
Presenting Author: Krystal Lai, MD – University of Texas Southwestern Medical Center
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 29th
8:50 AM - 9:00 AM PDT
67 - Relationship Between Clinical and Histologic Findings With Tulisokibart Induction at Week 12 and Maintenance Dosing at Week 50 in the Phase 2 Randomized Controlled ARTEMIS-UC Study in Participants With Ulcerative Colitis
Location: North Ballroom 120BC
Presenting Author: Brigid S. Boland, MD – Altman Clinical Translational Research Institute, University of California, San Diego
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 29th
9:00 AM - 9:10 AM PDT
58 - Symptoms Speak Louder Than Scores: Predicting Quality-of-Life Related to Esophageal Symptoms With EASY-E Questionnaire
68 - Guselkumab Maintenance Dose Regimens in Patients With High Disease Activity and Severity: Subgroup Analysis of Participants With Moderately to Severely Active Crohn’s Disease in the GALAXI Phase 3 Studies
69 - Clinical and Endoscopic Improvements With Risankizumab Treatment in Patients With Moderate-to-Severe Crohn’s Disease Who Previously Failed Ustekinumab
70 - Efficacy and Safety of Subcutaneous Guselkumab Rescue Therapy in Patients With Moderately to Severely Active Crohn’s Disease and Inadequate Response to Ustekinumab: Results From GALAXI 1, 2, & 3 Long-Term Extension
62 - Evaluation of Distensibility Index to Determine Procedural Success After Peroral Endoscopic Myotomy (POEM) for Non-Spastic Achalasia
Location: North Ballroom 120D
Presenting Author: Mark A. Solinski, MD – Feinberg School of Medicine, Northwestern University
Oral Paper PresentationAnnual Scientific Meeting
Wednesday, Oct 29th
9:40 AM - 9:50 AM PDT
72 - Real World Outcomes of Upadacitinib Compared to Risankizumab as Second-Line Therapy in Patients With Crohn’s Disease Exposed to Tumor Necrosis Factor-Alpha Inhibitors
73 - Efficacy and Safety of Obefazimod in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two, Phase 3, Randomised, Double-Blind, Placebo-Controlled, 8-Week Induction Trials (ABTECT 1 & 2) (Late-Breaking Abstract)
64 - Persistent Improvement in Dysphagia Symptoms for 52 Weeks Following a Single Administration of EP-104GI in RESOLVE, an Ongoing Phase 1b/2 Trial in Eosinophilic Esophagitis (Late-Breaking Abstract)